LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 6.06 | 84.90 | 1 | 365 | 0.0027 | -0.8787 | MN20160318_Q02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 6.06 | 84.90 | 806 | 365 | 2.2055 | 1.9117 | MN20160318_Q02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 7.77 | 84.90 | 1 | 411 | 0.0024 | -0.8579 | MN20160318_Q02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 7.77 | 84.90 | 834 | 411 | 2.0280 | 1.7286 | MN20160318_Q02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 7.77 | 84.90 | 4 | 411 | 0.0097 | -0.7387 | MN20160318_Q02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 7.77 | 84.90 | 876 | 411 | 2.1302 | 1.7881 | MN20160318_Q02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 9.47 | 84.90 | 1 | 447 | 0.0022 | -0.8431 | MN20160318_Q02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 9.47 | 84.90 | 932 | 447 | 2.0830 | 1.7160 | MN20160318_Q02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 9.47 | 84.90 | 1 | 447 | 0.0022 | -0.8431 | MN20160318_Q02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 9.47 | 84.90 | 951 | 447 | 2.1255 | 1.7390 | MN20160318_Q02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 11.18 | 84.90 | 1 | 492 | 0.0020 | -0.8265 | MN20160318_Q02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 11.18 | 84.90 | 1000 | 492 | 2.0310 | 1.6447 | MN20160318_Q02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 11.18 | 84.90 | 5 | 492 | 0.0102 | -0.6727 | MN20160318_Q02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 11.18 | 84.90 | 1040 | 492 | 2.1123 | 1.6859 | MN20160318_Q02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 12.88 | 84.90 | 3 | 531 | 0.0056 | -0.7174 | MN20160318_Q02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 12.88 | 84.90 | 1071 | 531 | 2.0169 | 1.6075 | MN20160318_Q02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 12.88 | 84.90 | 3 | 531 | 0.0056 | -0.7174 | MN20160318_Q02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 12.88 | 84.90 | 1112 | 531 | 2.0942 | 1.6448 | MN20160318_Q02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 14.58 | 84.90 | 4 | 663 | 0.0060 | -0.6430 | MN20160318_Q02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 14.58 | 84.90 | 1138 | 663 | 1.7154 | 1.3991 | MN20160318_Q02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 14.58 | 84.90 | 6 | 663 | 0.0090 | -0.5907 | MN20160318_Q02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 14.58 | 84.90 | 1194 | 663 | 1.7998 | 1.4382 | MN20160318_Q02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 16.29 | 84.90 | 8 | 766 | 0.0104 | -0.5247 | MN20160318_Q02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 16.29 | 84.90 | 1215 | 766 | 1.5844 | 1.3119 | MN20160318_Q02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 16.29 | 84.90 | 8 | 766 | 0.0104 | -0.5247 | MN20160318_Q02 | K13 |